Fe/Mg-Modified Carbonate Apatite with Uniform Particle Size and Unique Transport Protein-Related Protein Corona Efficiently Delivers Doxorubicin into Breast Cancer Cells

Abstract

Breast cancer is the abnormal, uncontrollable proliferation of cells in the breast. Conventional treatment modalities like chemotherapy induce deteriorating side effects on healthy cells. Non-viral inorganic nanoparticles (NPs) confer exclusive characteristics, such as, stability, controllable shape and size, facile surface modification, and unique magnetic and optical properties which make them attractive drug carriers. Among them, carbonate apatite (CA) particles are pH-responsive in nature, enabling rapid intracellular drug release, but are typically heterogeneous with the tendency to self-aggregate. Here, we modified the nano-carrier by partially substituting Ca2+ with Mg2+ and Fe3+ into a basic lattice structure of CA, forming Fe/Mg-carbonate apatite (Fe/Mg-CA) NPs with the ability to mitigate self-aggregation, form unique protein corona in the presence of serum and efficiently deliver doxorubicin (DOX), an anti-cancer drug into breast cancer cells. Two formulations of Fe/Mg-CA NPs were generated by adding different concentrations of Fe3+ and Mg2+ along with a fixed amount of Ca2+ in bicarbonate buffered DMEM (Dulbecco’s Modified Eagle’s Medium), followed by 30 min incubation at 37 °C. Particles were characterized by turbidity analysis, z-average diameter and zeta potential measurement, optical microscopy, field emission scanning electron microscopy (FESEM), Fourier transform infrared spectroscopy (FTIR), energy dispersive X-ray (EDX), flame atomic absorption spectroscopy (FAAS), pH dissolution, drug binding, cellular uptake, thiazolyl blue tetrazolium bromide (MTT) assay, stability analysis, and protein corona study by LCMS (Liquid chromatography-mass spectrometry). Both formulations of Fe/Mg-CA displayed mostly uniform nano-sized particles with less tendency to aggregate. The EDX and FAAS elemental analysis confirmed the weight (%) of Ca, Fe and Mg, along with their Ca/P ratio in the particles. A constant drug binding efficiency was noticed with 5 μM to 10 μM of initial DOX concentration. A pH dissolution study of Fe/Mg-CA NPs revealed the quick release of DOX in acidic pH. Enhancement of cytotoxicity for the chemotherapy drug was greater for Fe/Mg-CA NPs as compared to CA NPs, which could be explained by an increase in cellular internalization as a result of the small z-average diameter of the former. The protein corona study by LCMS demonstrated that Fe/Mg-CA NPs exhibited the highest affinity towards transport proteins without binding with opsonins. Biodistribution study was performed to study the effect of DOX-loaded Fe/Mg-CA NPs on the tissue distribution of DOX in Balb/c 4T1 tumor-bearing mice. Both formulations of Fe/Mg-CA NPs have significantly increased the accumulation of DOX in tumors. Interestingly, high Fe/Mg-CA NPs exhibited less off-target distribution compared to low Fe/Mg-CA NPs. Furthermore, the blood plasma analysis revealed prolonged blood circulation half-life of DOX-loaded low and high Fe/Mg-CA NPs compared to free DOX solution. Modifying CA NPs with Fe3+ and Mg2+, thereby, led to the generation of nano-sized particles with less tendency to aggregate, enhancing the drug binding efficiency, cellular uptake, and cytotoxicity without hampering drug release in acidic pH, while improving the circulation half-life and tumor accumulation of DOX. Therefore, Fe/Mg-CA which predominantly forms a transport protein-related protein corona could be a proficient carrier for therapeutic delivery in breast cancer.

Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics

“…The drug release from MNPs could present a constant profile (ultimately maintaining a constant concentration for a certain time) or a sigmoidal drug release, reaching a maximum concentration [ 88 ]. The use of MNPs as a chemotherapeutic vehicle has been studied [ 33 ] since the 1980s, and since then different formulations have been described that incorporate drugs such as DOX [ 89 ], paclitaxel (PTX) [ 90 ], and methotrexate (MTX) [ 91 ] as safer and potential alternatives for the treatment of different cancer types.…”

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics

“…Since August 2014, 74 completed clinical trials and 57 trails with the status of “active” or “recruited” have been listed in clinicaltrials.gov, over 40,000 citations have been recorded in PubMed on NP-based drug delivery [ 21 , 32 , 33 , 34 , 35 ], and many more are on several stages of drug pipelines [ 17 , 36 , 37 , 38 ]. Preclinical studies showed NPs with loaded genes or drug-enhanced antitumor effects with an improved pharmacokinetic profile compared to free drugs [ 39 , 40 , 41 ] by virtue of the unique physicochemical properties of NPs, including loading capacity for both hydrophobic and hydrophilic drugs, ease of functionalization with targeting moieties and hydrophilic molecules, stability and extended half-lives in the systemic circulation, facilitated tumor accumulation due to their small particle size and EPR effect, enhanced cellular internalization via endocytosis, and quick and sustained release of the drugs in response to various intracellular (e.g., acidic pH) and extracellular (e.g., magnetic field, laser) stimuli [ 42 , 43 , 44 ]. Additionally, the size, conformation, and surface properties of NPs navigate the trajectory dynamics of the NP-loaded drug complex and are considered fundamental driving forces for improved delivery efficiency [ 45 , 46 , 47 ].…”

Formulation and Cytotoxic Characterization of Trigonella foenum Loaded Polymeric Nanoparticles

“…Statistical analysis using unpaired t-test reveals that there was a significant difference (p<0.05) between the particle sizes obtained for nanoparticles containing different ratios of polymer. The polymer are comparatively having higher molecular weight, hence the amount of increased polymer may proportionally increase the mean particle size of prepared nanoparticles 15 . Dissolution velocity, wetting, particle surface area and saturation solubility are the vital parameter which can be increased to an extent by homogenization process of prepared herbal PNPs.…”